- Chronic Hemolysis
- Immunocompromised
- Fetus in utero
Pathology:
Cytotoxic to marrow erythroid progenitor cells by binding to red cell "P" antigen.
Clinical course:
Normal children: <2wk course. Anemia not present or appreciated.
Rx: Not required
Hemolytic patient: brief cessation of erythropoiesis may precipitate Aplastic crisis in already low lifespan RBC.
Most occurs once in life, but should should be isolated from at risk pts.
Rx: B.T if required.
Recovery in both the cases is spontaneous, with nucleated RBC & reticulocytosis.
Immuno-compromised: severe, no spontaneous recovery, >1 blood transfusion.
Rx: High dose IVIG.
In-Utero: ↑ 2nd, 3rd foetal wastage, hydrops fetalis.
Investigations:
Bone marrow under light m/s:
- decreased erythroid precursors,
- characteristic nuclear inclusions in erythroblasts
- giant pronormoblasts
Lab:
- PCR
- Serum IgM & IgG titers.
Comments
Post a Comment